Ameriprise
SLGC

Ameriprise’s SomaLogic, Inc. Class A Common Stock SLGC Stock Holding History

Ameriprise’s Portfolio SLGC Stock Details SLGC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-722,504
Closed -$8.95M – 4066
2021
Q3 		$8.95M Buy
+722,504
New +$8.15M ﹤0.01% 1945

Other funds holding SLGC

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
MAM
Madryn Asset Management New York $34.1M AUM
MSO
Madryn Select Opportunities New York $150M AUM
FCMV
Foresite Capital Management V Larkspur, California $271M AUM 309.87% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Ameriprise's SLGC Position: Q4 2021 in Review

Ameriprise sold out of SomaLogic, Inc. Class A Common Stock (SLGC) in Q4 2021, closing a stake of 722,504 shares — an estimated $8.95M sold.

Ameriprise first reported a position in SLGC in Q3 2021 and held it in 1 quarter. The position peaked at $8.95M in Q3 2021. 96 funds tracked by Wall St. Rank hold SLGC as of Q4 2021.

  • Ameriprise reported no remaining SomaLogic, Inc. Class A Common Stock position as of Q4 2021 after selling out during the quarter.
  • Ameriprise sold 722,504 SomaLogic, Inc. Class A Common Stock shares in Q4 2021, an estimated $8.95M.
  • Ameriprise first reported a position in SomaLogic, Inc. Class A Common Stock in Q3 2021 and held it in 1 quarter.
  • Ameriprise's SomaLogic, Inc. Class A Common Stock position peaked at $8.95M in Q3 2021.
  • 96 funds tracked by Wall St. Rank held SomaLogic, Inc. Class A Common Stock as of Q4 2021.

Based on Ameriprise's 13F filing for Q4 2021, filed 14 Feb 2022.